Several drugs already approved by the U.S. Food and Drug Administration (FDA) could potentially be used to alleviate the symptoms
Read more
against
Moscow starts inoculating vulnerable workers against coronavirus
Moscow on Saturday began vaccinating workers at high risk of becoming infected with the coronavirus at newly opened clinics across
Read more
Antibody Treatment Approved for Emergency Use Against Early COVID-19
TUESDAY, Nov. 10, 2020 — Eli Lilly’s experimental antibody treatment for COVID-19 was given emergency approval by the U.S. and
Read more
Moderna Announces Supply Agreement with the Ministry of Public Health to Supply Qatar with mRNA Vaccine Against COVID-19 (mRNA-1273)
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oct. 26, 2020– Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create
Read more
New class of highly effective inhibitors protects against neurodegeneration
Neurobiologists at Heidelberg University have discovered how a special receptor at neuronal junctions that normally activates a protective genetic program
Read more
Increasing the effectiveness of immunotherapy against skin cancer
The melanoma is a malignant tumor of the pigment cells. If diagnosed early, the tumor can be removed completely—and the
Read more
Tiny antibody component highly effective against SARS-COV-2 in animal studies
University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes
Read more
Patients taking long-term opioids produce antibodies against the drugs
University of Wisconsin-Madison scientists have discovered that a majority of back-pain patients they tested who were taking opioid painkillers produced
Read more
Another mRNA-based vaccine candidate protects animals against SARS-CoV-2
An experimental messenger RNA (mRNA)-based vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits protective immune responses in mice
Read more
UK’s vaccine against SARS-CoV-2 is safe and induces an immune reaction
Promising early stage results from a phase 1/2 clinical trial of the UK’s vaccine candidate against SARS-CoV-2 (the virus that
Read more